Paige AI

ZayaAI Integrates Paige’s Advanced AI Applications into Its Laboratory Information System (LIS)

Bucharest, Romania – May 12, 2025 – ZayaAI , a leading provider of AI-driven digital pathology solutions, is proud to announce the integration of Paige’s state-of-the-art AI-assisted diagnostic models into its Laboratory Information System (LIS). This strategic collaboration aims to enhance diagnostic efficiency and streamline pathology workflows across various cancer types. Paige’s AI applications, including Prostate, Breast and GI Suites and PanCancer Detect, are renowned for their ability to

Sonrai and Paige Partner to Bring Advanced Machine Learning Capabilities to Biopharma

The collaboration combines Sonrai's AI-driven multi-modal data management and analysis platform with Paige's proprietary foundation models to accelerate precision medicine research. Through the partnership, researchers and biopharma teams will be able to use cutting-edge AI, machine learning, and multi-modal data integration, regardless of technical expertise. BELFAST, NORTHERN IRELAND–Sonrai Analytics (Sonrai), a leading AI precision medicine company accelerating the development of therapeutics

Paige Launches New System-Wide AI Application for the Gastrointestinal Tract

AI-Assisted Diagnosis Across the Esophagus, Stomach, Duodenum, and Colorectum—Designed to Detect and Assess Disease Severity in Over 40 GI-Related Conditions NEW YORK–( BUSINESS WIRE )–Paige, leader in next-generation AI technology, today announced the launch of the Paige GI Suite, an AI-assisted diagnostic application designed to assist pathologists in detecting the most common conditions located within the gastrointestinal (GI) tract. Unlike other AI solutions that focus on a single tissue typ

Lumea and Paige Partner to Advance AI-Powered Digital Pathology

Lumea and Paige partner to integrate AI-powered workflows, enhancing diagnostic efficiency and accessibility in cancer care. Lehi, Utah – June 3, 2025 – Lumea , the U.S. leader in primary clinical digital pathology, today announced a partnership with Paige, a leader in next-generation AI technology, to expand the integration and impact of AI-powered workflows across pathology practices. This collaboration brings together Lumea’s FDA-cleared digital pathology platform with Paige’s advanced AI-ass

U.S. FDA Grants Paige Breakthrough Device Designation for AI Application that Detects Cancer Across Different Anatomic Sites

Paige PanCancer Detect recognized by FDA as a Breakthrough Device intended to assist pathologists in the detection of cancer across multiple tissue and organ types NEW YORK- (BUSINESS WIRE) -Paige, a leader in next-generation AI technology, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to Paige PanCancer Detect * , an AI-assisted diagnostic application intended to assist pathologists in the detection of foci that are suspicious for c